During the past decade, IU Health Arnett Cancer Care conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 53 clinical trials were completed, i.e. on average, 331.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 26 clinical trials were completed. i.e. 866.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IU Health Arnett Cancer Care" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "Hoosier Cancer Research Network" with 12 trials sponsored, "SWOG Cancer Research Network" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored and "Eastern Cooperative Oncology Group" with 6 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IU Health Arnett Cancer Care" #1 collaborator was "National Cancer Institute (NCI)" with 29 trials as a collaborator, "Walther Cancer Institute" with 12 trials as a collaborator, "Hoosier Cancer Research Network" with 7 trials as a collaborator, "Genentech, Inc." with 6 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 59 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "IU Health Arnett Cancer Care" are "Breast Cancer" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Colorectal Cancer" (6 trials), "Recurrent Breast Carcinoma" (6 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials). Many other conditions were trialed in "IU Health Arnett Cancer Care" in a lesser frequency.

Most popular intervention types in "IU Health Arnett Cancer Care" are "Drug" (73 trials), "Other" (37 trials), "Biological" (26 trials), "Procedure" (5 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Bevacizumab" (14 trials), "Docetaxel" (9 trials), "Quality-of-Life Assessment" (9 trials) and "Paclitaxel" (8 trials). Other intervention names were less common.

The vast majority of trials in "IU Health Arnett Cancer Care" are 61 trials for "All" genders, 14 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "IU Health Arnett Cancer Care". undefined are not yet recruiting, 1 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in IU Health Arnett Cancer Care, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in IU Health Arnett Cancer Care, 4 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".